Sedation As Adjunct To Anesthesia — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for sedation as adjunct to anesthesia. 10 active patents protecting 2 drugs from 1+ originators. First major cliff: 2034. Daily refresh.

2
Approved drugs
10
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in Sedation As Adjunct To Anesthesia

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Wyeth/Pfizer) 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating sedation as adjunct to anesthesia. Each bar = one year. Y-axis scaled to peak year (4 patents).

4
28
4
34
2
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Versed
midazolam
 Generic (originally Roche) 6 61 — 2028-01-18
Ativan
lorazepam
 Generic (originally Wyeth/Pfizer) 4 64 — 2034-01-08

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8217033 Versed method of use 75 2028-01-18
9289432 Versed method of use 75 2028-01-18
9687495 Versed method of use 75 2028-01-18
8999393 Ativan method of use 70 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8809322 Versed formulation 55 2028-01-18
10966990 Versed formulation 42 2038-06-20
10966990 Versed formulation 42 2038-06-20

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10966990 Versed formulation 42 2038-06-20
10966990 Versed formulation 42 2038-06-20
8809322 Versed formulation 55 2028-01-18
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 62 2034-01-08
8999393 Ativan method of use 70 2034-01-08
9687495 Versed method of use 75 2028-01-18
9289432 Versed method of use 75 2028-01-18
8217033 Versed method of use 75 2028-01-18

Related